Clinical decision-making on spinal cord injury-associated pneumonia: a nationwide survey in Germany.


Journal

Spinal cord
ISSN: 1476-5624
Titre abrégé: Spinal Cord
Pays: England
ID NLM: 9609749

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 21 01 2020
accepted: 03 02 2020
revised: 29 01 2020
pubmed: 20 2 2020
medline: 2 7 2021
entrez: 20 2 2020
Statut: ppublish

Résumé

Survey study. Spinal cord injury (SCI)-associated pneumonia (SCI-AP) is associated with poor functional recovery and a major cause of death after SCI. Better tackling SCI-AP requires a common understanding on how SCI-AP is defined. This survey examines clinical algorithms relevant for diagnosis and treatment of SCI-AP. All departments for SCI-care in Germany. The clinical decision-making on SCI-AP and the utility of the Centers for Disease Control and Prevention (CDC) criteria for diagnosis of 'clinically defined pneumonia' were assessed by means of a standardized questionnaire including eight case vignettes of suspected SCI-AP. The diagnostic decisions based on the case information were analysed using classification and regression trees (CART). The majority of responding departments were aware of the CDC-criteria (88%). In the clinical vignettes, 38-81% of the departments diagnosed SCI-AP in accordance with the CDC-criteria and 7-41% diagnosed SCI-AP in deviation from the CDC-criteria. The diagnostic agreement was not associated with the availability of standard operating procedures for SCI-AP management in the departments. CART analysis identified radiological findings, fever, and worsened gas exchange as most important for the decision on SCI-AP. Frequently requested supplementary diagnostics were microbiological analyses, C-reactive protein, and procalcitonin. For empirical antibiotic therapy, the departments used (acyl-)aminopenicillins/β-lactamase inhibitors, cephalosporins, or combinations of (acyl-)aminopenicillins/β-lactamase inhibitors with fluoroquinolones or carbapenems. This survey reveals a diagnostic ambiguity regarding SCI-AP despite the awareness of CDC-criteria and established SOPs. Heterogeneous clinical practice is encouraging the development of disease-specific guidelines for diagnosis and management of SCI-AP.

Identifiants

pubmed: 32071433
doi: 10.1038/s41393-020-0435-5
pii: 10.1038/s41393-020-0435-5
pmc: PMC7223654
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

873-881

Subventions

Organisme : ACL HHS
ID : 90SI5020
Pays : United States

Références

Grossman RG, Toups EG, Frankowski RF, Burau KD, Howley S. North American Clinical Trials Network for the Treatment of Spinal Cord Injury: goals and progress. J Neurosurg Spine. 2012;17:6–10.
pubmed: 22985365 doi: 10.3171/2012.4.AOSPINE1294
DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil. 1999;80:1411–9.
pubmed: 10569435 doi: 10.1016/S0003-9993(99)90252-6
Savic G, DeVivo MJ, Frankel HL, Jamous MA, Soni BM, Charlifue S. Causes of death after traumatic spinal cord injury-a 70-year British study. Spinal Cord. 2017;55:891–7.
pubmed: 28631749 doi: 10.1038/sc.2017.64
Thietje R, Kowald B, Hirschfeld S. What are the causes of death in patients with spinal cord injury today?—a descriptive analysis of 102 cases. Rehabilitation. 2011;50:251–4.
pubmed: 21647849 doi: 10.1055/s-0031-1273774
Failli V, Kopp MA, Gericke C, Martus P, Klingbeil S, Brommer B, et al. Functional neurological recovery after spinal cord injury is impaired in patients with infections. Brain. 2012;135:3238–50.
pubmed: 23100450 doi: 10.1093/brain/aws267
Kopp MA, Watzlawick R, Martus P, Failli V, Finkenstaedt FW, Chen Y, et al. Long-term functional outcome in patients with acquired infections after acute spinal cord injury. Neurology. 2017;88:892–900.
pubmed: 28130472 pmcid: 5331871 doi: 10.1212/WNL.0000000000003652
Jaja BNR, Jiang F, Badhiwala JH, Schar R, Kurpad S, Grossman RG et al. Association of pneumonia, wound infection, and sepsis with clinical outcomes after acute traumatic spinal cord injury. J Neurotrauma. 2019. https://doi.org/10.1089/neu.2018.6245 .
Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.
pubmed: 18538699 doi: 10.1016/j.ajic.2008.03.002
Resnick DK. Updated guidelines for the management of acute cervical spine and spinal cord injury. Neurosurgery. 2013;72:1.
pubmed: 23417171 doi: 10.1227/NEU.0b013e318276ee7e
Fehlings MG, Tetreault LA, Wilson JR, Kwon BK, Burns AS, Martin AR, et al. A clinical practice guideline for the management of acute spinal cord injury: introduction, rationale, and scope. Glob Spine J. 2017;7:84s–94s.
doi: 10.1177/2192568217703387
Aarabi B, Harrop JS, Tator CH, Alexander M, Dettori JR, Grossman RG, et al. Predictors of pulmonary complications in blunt traumatic spinal cord injury. J Neurosurg Spine. 2012;17:38–45.
pubmed: 22985369 doi: 10.3171/2012.4.AOSPINE1295
Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6:775–86.
pubmed: 16163382 doi: 10.1038/nrn1765
Riegger T, Conrad S, Liu K, Schluesener HJ, Adibzahdeh M, Schwab JM. Spinal cord injury-induced immune depression syndrome (SCI-IDS). Eur J Neurosci. 2007;25:1743–7.
pubmed: 17432962 doi: 10.1111/j.1460-9568.2007.05447.x
Riegger T, Conrad S, Schluesener HJ, Kaps HP, Badke A, Baron C, et al. Immune depression syndrome following human spinal cord injury (SCI): a pilot study. Neuroscience. 2009;158:1194–9.
pubmed: 18790013 doi: 10.1016/j.neuroscience.2008.08.021
Brommer B, Engel O, Kopp MA, Watzlawick R, Muller S, Pruss H, et al. Spinal cord injury-induced immune deficiency syndrome enhances infection susceptibility dependent on lesion level. Brain. 2016;139:692–707.
pubmed: 26754788 pmcid: 5014125 doi: 10.1093/brain/awv375
Lucin KM, Sanders VM, Jones TB, Malarkey WB, Popovich PG. Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp Neurol. 2007;207:75–84.
pubmed: 17597612 pmcid: 2023967 doi: 10.1016/j.expneurol.2007.05.019
Pruss H, Tedeschi A, Thiriot A, Lynch L, Loughhead SM, Stutte S, et al. Spinal cord injury-induced immunodeficiency is mediated by a sympathetic-neuroendocrine adrenal reflex. Nat Neurosci. 2017;20:1549–59.
pubmed: 28920935 doi: 10.1038/nn.4643
Druschel C, Schaser KD, Schwab JM. Current practice of methylprednisolone administration for acute spinal cord injury in Germany: a national survey. Spine (Philos Pa 1976). 2013;38:E669–77.
doi: 10.1097/BRS.0b013e31828e4dce
Harms H, Hoffmann S, Malzahn U, Ohlraun S, Heuschmann P, Meisel A. Decision-making in the diagnosis and treatment of stroke-associated pneumonia. J Neurol Neurosurg Psychiatry. 2012;83:1225–30.
pubmed: 23024353 doi: 10.1136/jnnp-2012-302194
Crichton NJ, Hinde JP, Marchini J. Models for diagnosing chest pain: is CART helpful? Stat Med. 1997;16:717–27.
pubmed: 9131760 doi: 10.1002/(SICI)1097-0258(19970415)16:7<717::AID-SIM504>3.0.CO;2-E
Hastie T, Tibshirani R, Friedman, J. The elements of statistical learning. 2nd ed. Ch. 9.2.3., 12th printing. Springer Nature. p. 308–309.
Therneau T, Atkinson B, Ripley B. rpart: Recurisve Partitioning and Regression Trees. Comprehensive R Archive Network (CRAN), 2017; R package version 4.1-11.
Rebecca J, Sela JSS. REEMtree: regression trees with random effects. R package version 0.90.3. Comprehensive R Archive Network (CRAN), 2011.
Klein Klouwenberg PM, Ong DS, Bos LD, de Beer FM, van Hooijdonk RT, Huson MA, et al. Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med. 2013;41:2373–8.
pubmed: 23921277 doi: 10.1097/CCM.0b013e3182923712
Kishore AK, Vail A, Chamorro A, Garau J, Hopkins SJ, Di Napoli M, et al. How is pneumonia diagnosed in clinical stroke research? A systematic review and meta-analysis. Stroke. 2015;46:1202–9.
pubmed: 25858238 doi: 10.1161/STROKEAHA.114.007843
Esayag Y, Nikitin I, Bar-Ziv J, Cytter R, Hadas-Halpern I, Zalut T, et al. Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia. Am J Med. 2010;123:88.e1–5.
doi: 10.1016/j.amjmed.2009.09.012
Nelson MLA, McKellar KA, Yi J, Kelloway L, Munce S, Cott C, et al. Stroke rehabilitation evidence and comorbidity: a systematic scoping review of randomized controlled trials. Top Stroke Rehabil. 2017;24:374–80.
pubmed: 28218020 doi: 10.1080/10749357.2017.1282412
Ostwald SK, Wasserman J, Davis S. Medications, comorbidities, and medical complications in stroke survivors: the CAReS study. Rehabil Nurs. 2006;31:10–4.
pubmed: 16422039 pmcid: 1405842 doi: 10.1002/j.2048-7940.2006.tb00004.x
Smith CJ, Kishore AK, Vail A, Chamorro A, Garau J, Hopkins SJ, et al. Diagnosis of stroke-associated pneumonia: recommendations from the Pneumonia in Stroke Consensus Group. Stroke. 2015;46:2335–40.
pubmed: 26111886 doi: 10.1161/STROKEAHA.115.009617
Luyt CE, Guerin V, Combes A, Trouillet JL, Ayed SB, Bernard M, et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2005;171:48–53.
pubmed: 15447947 doi: 10.1164/rccm.200406-746OC
van der Meer V, Neven AK, van den Broek PJ, Assendelft WJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ. 2005;331:26.
pubmed: 15979984 pmcid: 558535 doi: 10.1136/bmj.38483.478183.EB
Kopp MA, Druschel C, Meisel C, Liebscher T, Prilipp E, Watzlawick R, et al. The SCIentinel study–prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS)–study protocol and interim feasibility data. BMC Neurol. 2013;13:168.
pubmed: 24206943 pmcid: 3827331 doi: 10.1186/1471-2377-13-168
Nachtigall I, Tamarkin A, Tafelski S, Deja M, Halle E, Gastmeier P, et al. Impact of adherence to standard operating procedures for pneumonia on outcome of intensive care unit patients. Crit Care Med. 2009;37:159–66.
pubmed: 19050600 doi: 10.1097/CCM.0b013e3181934f1b
Dalhoff K, Abele-Horn M, Andreas S, Deja M, Ewig S, Gastmeier P, et al. Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia—update 2017—S3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy, the German Radiological Society and the Society for Virology. Pneumologie. 2018;72:15–63.
pubmed: 29341032 doi: 10.1055/s-0043-121734
Hetze S, Engel O, Romer C, Mueller S, Dirnagl U, Meisel C, et al. Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: a bed to bench approach. J Cereb Blood Flow Metab. 2013;33:846–54.
pubmed: 23361393 pmcid: 3677122 doi: 10.1038/jcbfm.2013.6
Liberati A, D’Amico R, Pifferi S, Telaro E. Antibiotic prophylaxis in intensive care units: meta-analyses versus clinical practice. Intensive Care Med. 2000;26:S38–44.
pubmed: 10786957 doi: 10.1007/s001340051117
Sirvent JM, Torres A, El-Ebiary M, Castro P, de Batlle J, Bonet A. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med. 1997;155:1729–34.
pubmed: 9154884 doi: 10.1164/ajrccm.155.5.9154884
Kalra L, Irshad S, Hodsoll J, Simpson M, Gulliford M, Smithard D, et al. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. Lancet. 2015;386:1835–44.
pubmed: 26343840 doi: 10.1016/S0140-6736(15)00126-9
Westendorp WF, Vermeij JD, Zock E, Hooijenga IJ, Kruyt ND, Bosboom HJ, et al. The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet. 2015;385:1519–26.
pubmed: 25612858 doi: 10.1016/S0140-6736(14)62456-9
Filion FL. Estimating bias due to nonresponse in mail surveys. Publ Opin Q. 1976;39:482–92.
doi: 10.1086/268245
Furlan JC, Sakakibara BM, Miller WC, Krassioukov AV. Global incidence and prevalence of traumatic spinal cord injury. Can J Neurol Sci. 2013;40:456–64.
pubmed: 23786727 doi: 10.1017/S0317167100014530

Auteurs

Claudia Druschel (C)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Clinical and Experimental Spinal Cord Injury Research (Neuroparaplegiology), Charité-Universitätsmedizin Berlin, Berlin, Germany.
Department of Orthopaedic and Trauma Surgery, Universitätsklinikum Carl-Gustav Carus, Dresden, Germany.

Ramin R Ossami Saidy (RR)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Clinical and Experimental Spinal Cord Injury Research (Neuroparaplegiology), Charité-Universitätsmedizin Berlin, Berlin, Germany.
Department of Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Ulrike Grittner (U)

Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.

Claus P Nowak (CP)

Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.

Andreas Meisel (A)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Klaus-Dieter Schaser (KD)

Department of Orthopaedic and Trauma Surgery, Universitätsklinikum Carl-Gustav Carus, Dresden, Germany.

Andreas Niedeggen (A)

Treatment Centre for Spinal Cord Injuries, Trauma Hospital Berlin, Berlin, Germany.

Thomas Liebscher (T)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Clinical and Experimental Spinal Cord Injury Research (Neuroparaplegiology), Charité-Universitätsmedizin Berlin, Berlin, Germany.
Treatment Centre for Spinal Cord Injuries, Trauma Hospital Berlin, Berlin, Germany.

Marcel A Kopp (MA)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany. marcel.kopp@charite.de.
Clinical and Experimental Spinal Cord Injury Research (Neuroparaplegiology), Charité-Universitätsmedizin Berlin, Berlin, Germany. marcel.kopp@charite.de.
Berlin Institute of Health (BIH), Berlin, Germany. marcel.kopp@charite.de.
Berlin Institute of Health, QUEST-Center for Transforming Biomedical Research, Berlin, Germany. marcel.kopp@charite.de.

Jan M Schwab (JM)

Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
Clinical and Experimental Spinal Cord Injury Research (Neuroparaplegiology), Charité-Universitätsmedizin Berlin, Berlin, Germany.
Department of Neurology, Spinal Cord Medicine (Paraplegiology), The Neurological Institute, The Ohio State University, Wexner Medical Center, Columbus, OH, USA.
Belford Center for Spinal Cord Injury, Departments of Neuroscience and Physical Medicine and Rehabilitation, The Neurological Institute, The Ohio State University, Wexner Medical Center, Columbus, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH